Welcome to Sathgen Therapeutics
We are a clinical-stage biotech company committed to discovering and developing innovative treatments for cancer patients to improve quality of life. Our lead drug candidate is in phase I clinical trials in patients with advanced solid tumors, as well as in healthy individuals – to evaluate safety, tolerability and pharmacokinetics of the drug.
We are focused on developing pioneering therapies to fight cancer. As a division of Godavari Biorefineries Limited, we are backed by a strong financial support from a conglomerate that produces foods, biofuels, chemicals, pharmaceutical intermediates, power, compost, biomaterials, and related products. Our state-of-the-art R&D facility and expertise in anti-cancer drug design & development make us a strong player in the fight against cancer.
